Literature DB >> 11322652

Podophyllotoxin lignans enhance IL-1beta but suppress TNF-alpha mRNA expression in LPS-treated monocytes.

N Pugh1, I A Khan, R M Moraes, D S Pasco.   

Abstract

There exists a growing body of research which indicates that antimitotics such as taxol and colchicine influence cytokine gene expression. In the present study we examined the effect of podophyllotoxin and six analogs on nuclear factor kappa B (NF-kappa B) activation, and on interleukin-1 beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) mRNA expression in human THP-1 monocytes. All compounds were inactive between 0.001microM and 10microM when tested alone. However, podophyllotoxin (0.1 microM) enhanced LPS-induced NF-kappa B activation and IL-1beta mRNA expression between 2 and 3-fold. In contrast, LPS-induced TNF-alpha mRNA expression was decreased between 3 and 6-fold. Comparable results were also observed with the three analogs acetylpodophyllotoxin, 4'-demethylpodophyllotoxin and alpha-peltatin. The remaining three analogs (podophyllotoxin-4-O-glucoside, beta-peltatin-beta-D-glucopyransoide and 1,2,3,4-dehydrodesoxypodophyllotoxin) were inactive. Clearly certain structural features such as the presence of a glycosidic group or ring aromatization results in loss of biological activity. Interestingly, the analogs that were inactive in our assays have also been previously shown to lack affinity for tubulin binding. These results suggest that during the initial hours of exposure to podophyllotoxin or specific analogs these compounds do not act as independent stimulants of human monocyte activation, but can selectively enhance or suppress LPS-induced cytokine gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322652     DOI: 10.1081/iph-100102570

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  6 in total

Review 1.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

2.  Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

Authors:  Jin-Hui Song; Dong-Xue Sun; Bin Chen; Dai-Hong Ji; Jie Pu; Jie Xu; Feng-De Tian; Lin Guo
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

3.  Temperature-dependent growth and emergence of functional leaves: an adaptive mechanism in the seedlings of the western Himalayan plant Podophyllum hexandrum.

Authors:  Rekha Kushwaha; Subedar Pandey; Sanjoy Chanda; Amita Bhattacharya; Paramvir Singh Ahuja
Journal:  J Plant Res       Date:  2008-03-13       Impact factor: 2.629

4.  An efficient method of propagation of Podophyllum hexandrum: an endangered medicinal plant of the Western Himalayas under ex situ conditions.

Authors:  Amit C Kharkwal; Rekha Kushwaha; Om Prakash; R K Ogra; Amita Bhattacharya; P K Nagar; Paramvir Singh Ahuja
Journal:  J Nat Med       Date:  2008-01-09       Impact factor: 2.343

Review 5.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

6.  Podophyllum hexandrum Offers Radioprotection by Modulating Free Radical Flux: Role of Aryl-Tetralin Lignans.

Authors:  Raman Chawla; Rajesh Arora; Shikha Singh; R K Sagar; Rakesh Kumar Sharma; R Kumar; A Sharma; R P Tripathi; S C Puri; H A Khan; A S Shawl; P Sultan; Tej Krishan; G N Qazi
Journal:  Evid Based Complement Alternat Med       Date:  2006-06-21       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.